cdmo.directory
← Compare landing

CMC Pharmaceuticals, Inc. vs Dipharma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cmcpharm/dipharma

CategoryCMC Pharmaceuticals, Inc.Dipharma
Listed sitecdmocdmo
SummaryCMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Solon, Ohio, United States
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.